PharmaCorp Rx Inc. Files Final Short Form Base Shelf Prospectus

Executive Summary

• PharmaCorp Rx Inc. filed a Final Short Form Base Shelf Prospectus with Canadian securities regulators, permitting up to $100 million of various securities to be offered over the next 25 months.
• The prospectus provides flexibility for future capital raises to fund strategic acquisitions and expansion of its pharmacy network under the PharmaChoice Canada banner.
• No securities have been issued yet; the filing is a preparatory step that could support growth initiatives pending market conditions and financing needs.

Key Details

• Prospectus Filing: Final Short Form Base Shelf Prospectus dated October 14, 2025 filed in all Canadian provinces except Quebec.
• Maximum Offering Size: Up to $100 million of common shares, preferred shares, warrants, debt securities, subscription receipts, units, or any combination thereof.
• Offering Period: 25‑month effectiveness period from the date the prospectus becomes effective.
• Securities Types Allowed: Common and preferred equity, warrants, debt instruments, subscription receipts, and unit packages.
• Future Offering Process: Specific terms for each offering will be set out in a Prospectus supplement filed with regulators at the time of any issuance.
• Purpose of Capital: Intended to meet the Corporation’s financial requirements and support strategic acquisitions and expansion opportunities across Canada, particularly through its alliance with PharmaChoice Canada.
• Executive Quote: Alan Simpson, Executive Chairman, highlighted that the filing “marks an important step forward” and provides flexibility to access capital for growth.
• Regulatory Access: Prospectus is available on SEDAR+ (www.sedarplus.ca).

Notable Quotes

“The filing of our final base shelf prospectus marks an important step forward in PharmaCorp’s growth journey… With this framework now in place, we have the flexibility to efficiently access capital as we continue to pursue strategic acquisitions and expansion opportunities across Canada.” – Alan Simpson, Executive Chairman

Materiality Assessment: Non‑Material – Positive (the filing itself does not result in immediate financing or revenue but provides a material tool for future growth).